News
Lunchtime Seminar: Willingness-to-Pay
9 June 2010
On 16 July, OHE will present a Lunchtime Seminar by Prof Peter Zweifel, who will discuss his recent research on patients’ willingness to pay for pharmaceuticals.…
Biosimilars and Data Exclusivity
8 June 2010
Data exclusivity is critical to ensuring that biosimilars achieve an appropriate balance between increasing market competition and encouraging innovation. The history of ‘traditional generics’ is a…
News Release: Report on Patient Choice in the UK
4 June 2010
A report published today by The King’s Fund shows that having a choice of hospitals is valued by the majority of patients. However, it is not…
Reminder: Risk Sharing Master Class
3 June 2010
On 29 June, OHE will collaborate with the Pope Woodhead consultancy to present a workshop on implementing risk sharing and patient access schemes within a market…
Biosimilars: Issues Overview
1 June 2010
This is the second in our series of posts based on the OHE seminar on biosimilars and summarises the remarks of Prof Bengt Jönsson of the…
2010 Lecture: US Health Care Reform
27 May 2010
OHE’s 2010 Annual Lecture features Dr Alan Garber on the implications of the American health care reform law. Register to join us in London on 22…
The Impact of Biosimilars on Markets
24 May 2010
The availability of biosimilars — ‘copies’ of biologics — is very recent and limited so far to only a few products. Projecting the impact on markets…
HTAinSite: The NICE Decision Database
18 May 2010
HTAinSite is a unique resource that enables subscribers to quickly find relevant information on NICE technology appraisal (TA) decisions and the evidence used to support them.…
Workshop on HTA and Regulatory Review
13 May 2010
Tensions between broad access to new medical technologies and efforts to contain health care costs are perennial. In recent years, this has become evident in the…